Position in ALT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$612,979
-$1,626,183 QoQ
Shares Held
201,638
-72.3% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 210 holders
Holding Since
Sep 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,139,216,221 across 217 Biotechnology names. ALT ranks #164 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in ALT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $612,979 | 201,638 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,239,162 | 727,001 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,850,334 | 1,343,583 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,358,689 | 360,395 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $198,368 | 51,258 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $252,580 | 50,516 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,315,395 | 459,833 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,654,144 | 758,004 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,069,706 | 762,362 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,607,282 | 354,350 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,259,417 | 289,726 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,899,902 | 730,732 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,779,959 | 504,238 | Shares | Defined | 2023-08-14 | |
| 2022-12-31 | $455,697 | 27,702 | Shares | Defined | 2023-02-14 | |
| 2022-06-30 | $1,985,290 | 169,683 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $5,893,511 | 967,736 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $10,820,130 | 1,181,237 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $10,806,002 | 955,438 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,153,395 | 827,756 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $18,592,450 | 1,315,814 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $13,464,867 | 1,193,694 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $21,922,956 | 1,660,830 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||